Atlas Venture Fund X, L.P. - 18 May 2021 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
10%+ Owner
Signature
Atlas Venture Fund X, L.P., By: Atlas Venture Associates X, L.P., its general partner, by Atlas Associates X, LLC, its general partner, By: Ommer Chohan, Chief Financial Officer /s/ Ommer Chohan
Issuer symbol
KYMR
Transactions as of
18 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 18:17:26 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYMR Common Stock Other $0 -1,122,619 -16% $0.000000 5,763,012 18 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represent a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund X, L.P. to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted in accordance with Rule 10b5-1 on November 17, 2020.